Sanofi and MannKind Announce Global Licensing Agreement for Afrezza (insulin human) Rapid-Acting Inhaled Insulin

By: via Benzinga
Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that they have entered into a worldwide ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.